Latest stories on INTI
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
Business Insider73 · bullishproduct/pr
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
Business Insider73 · bullishproduct/pr
Amplia Announces Publication of New FAK Inhibitor Patent Application
Business Insider59 · neutralproduct/pr
Amplia Announces Publication of New FAK Inhibitor Patent Application | INNMF Stock News
StockTitan63 · neutralproduct/pr
cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD
PR Newswire63 · neutralgeneral
N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease
Morningstar59 · neutralproduct/pr
MEKanistic Therapeutics Announces FDA Clearance of IND for MTX-531, Enabling Phase 1 Trial in Advanced Solid Tumors
PR Newswire63 · neutralproduct/pr